SCHEMBL5504175

SCHEMBL5504175

O=c1c2oc3c(OC(F)F)cccc3c2cnn1C1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PDE9A O76083 18/20 0.37
TNF P01375 2/20 0.34
LITAF Q99732 2/20 0.34
PDE1C Q14123 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL72926 0.80 PDE4D (0.37) PDE9APDE1C
SCHEMBL3873741 0.76 PDE4B (0.36)
SCHEMBL84902 0.73 PDE4D (0.54)
SCHEMBL3872957 0.71 MAPT (0.35) PDE9A
SCHEMBL29703260 0.63 GAA (0.47) PDE9APDE1C
SCHEMBL5501126 0.61 ADORA2A (0.39)
SCHEMBL30881895 0.60 SMN1; SMN2 (0.47)
SCHEMBL28282726 0.57 ADRA1A (0.39)
SCHEMBL10670636 0.56 BRD4 (0.45) PDE9A
SCHEMBL9828687 0.56 CNR2 (0.60) PDE9APDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831227-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS Glenmark Pharmaceuticals S.A. (CH) 2007-09-12 EP claimed
WO-2006064355-A2 NOVEL HETEROCYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS GLENMARK PHARMACEUTICALS S.A. (US) 2006-06-22 WO claimed